Home › Trials › NCT06823583
Clinical trial Recruiting at 1 site Observational Ages 19 and up

Understanding what to expect after getting a Ventricular Assist Device

Official title: Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool

Run by Bryan Heart · NCT06823583 · Data updated 2026-11-12

This study is trying to help patients understand what to expect after getting a Ventricular Assist Device for heart failure, so they can feel more at ease and improve their quality of life.

Quick facts

Study typeObservational
Ages19 Years and up
SexAll
Enrollment10 (estimated)
SponsorBryan Heart
Academic / other
Locations2 sites (Lincoln, Nebraska and 1 other locations)
StatusRecruiting
StartedAugust 17, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedSeptember 19, 2025
Trial IDNCT06823583 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are English-speaking adults aged 19 and older who are scheduled for VAD implantation.

Probably not a fit

Patients who are not scheduled for VAD surgery or are non-English speaking may not receive any benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to enhance patient education regarding the expectations and outcomes following the implantation of a Ventricular Assist Device (VAD) for advanced heart failure. By utilizing an anticipatory guidance tool developed from previous patient responses, the study seeks to identify common areas of satisfaction and concern at various time points post-implantation. The goal is to improve health-related quality of life and reduce anxiety and depression among patients by providing comprehensive information about their journey after receiving a VAD.

Why it matters

Potential benefit: If successful, this study could significantly improve the quality of life for patients by providing them with better understanding and expectations post-VAD implantation.

How similar studies have gone: While anticipatory guidance models are common in pediatric care, this approach for adults with chronic conditions like heart failure is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

(For patient inclusion):

* scheduled for a VAD implantation
* English-speaking as the VAD AG Tool v5.0 has not yet been translated beyond English age ≥19 years at the time of implant as most states in North America have an age of majority for consent signing.

(-VAD clinician for the clinician evaluation process)

Exclusion Criteria:

* Not scheduled for VAD surgery
* Non English speaking
* \<19 yrs of age (Not a VAD Clinician for the clinician evaluation process)

Where it's running

  • Bryan Heart
    Lincoln, Nebraska, United States     Recruiting
  • Advocate Aurora Health
    Milwaukee, Wisconsin, United States     Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Advanced Heart Failure 7
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.